Dr. William Bozza recently joined the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute as a Program Director. He currently manages a portfolio of oncology startups, SBIR and STTR awardees, helping small businesses commercialize innovative technologies for cancer diagnosis and therapeutics.

Prior to joining NCI, Dr. Bozza served in the FDA as a Regulatory Scientist specializing in chemistry, manufacturing, and control (CMC) review of drug applications.

Dr. William Bozza holds a PhD in Biochemistry from the University of Delaware.